Welcome to our dedicated page for Universal SEC filings (Ticker: UVV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Universal Corporation filings document financial results, material agreements, governance actions, and capital-structure matters for its agriproducts business. Recent Form 8-K reports furnish quarterly results releases, disclose an unsecured credit agreement with term loan and revolving credit facilities, and describe registered common stock with no par value traded on the New York Stock Exchange under UVV.
The company’s regulatory filings also cover executive officer appointments, related compensation arrangements, board composition, annual meeting voting results, auditor ratification, lead independent director designation, and shareholder-approved equity incentive awards. These disclosures connect Universal’s public-company governance and financing arrangements with its Tobacco Operations and Ingredients Operations.
Universal Corporation (UVV) notice of proposed sale: an individual plans to sell 10,000 common shares on or about 08/26/2025 on the NYSE with an aggregate market value reported as $554,458.00. The filing shows the shares were acquired from the issuer as equity compensation: 6,999 performance shares granted on 05/30/2025 and 3,001 restricted stock awards granted on 06/02/2025, with payment characterized as equity compensation. The filer reports 24,886,204 shares outstanding for the class and indicates no sales by the same person in the prior three months.
Universal Corporation director Robert C. Sledd reported a sale of company stock while retaining a meaningful stake. On 08/15/2025 he disposed of 4,617 shares at $53.25 per share, reducing his direct holdings but leaving him with 15,698 shares in total. The remaining stake includes 2,290 restricted stock units and 1,950 shares of restricted stock, indicating part of his ownership is subject to vesting or transfer restrictions. The Form 4 shows this was an individual filing by a director and identifies the transaction as a sell of common stock.
Form 144 notice from a holder of Universal Corporation (UVV) securities discloses a proposed sale of 4,617 common shares on the NYSE with an aggregate market value of $244,225.60 and total shares outstanding of 24,886,204. The shares were acquired as restricted stock units (RSUs): 1,792 shares vested/acquired on 08/02/2021 and 2,825 shares on 08/08/2025. No securities of the issuer were reported sold by the filer in the past three months. The filer affirms they do not possess undisclosed material adverse information about the issuer and acknowledges criminal penalties for intentional misstatements.
Universal Corp (UVV) director Lennart R. Freeman reported selling 2,800 shares of common stock on 08/11/2025 at a weighted average price of $52.8946, with trade prices ranging from $52.827 to $52.91. After the disposition the reporting person beneficially owns 19,669 shares, which include 2,290 restricted stock units. The Form 4 records the ownership as direct and shows no derivative security transactions. Footnotes state the reported price is a weighted average from multiple trades and offer to provide transaction-level detail on request. No amendments or other transactions are reported on this form.
Universal Corporation (UVV) filed a Form 144 reporting a proposed sale of 2,800 common shares with an aggregate market value of $146,675.95, intended to be sold on the NYSE on 08/11/2025. The shares were acquired through grants on 08/04/2017 (908 shares), 08/02/2019 (1,420 shares) and 08/03/2022 (472 shares), which together equal the amount disclosed for sale. The filing lists 24,886,204 shares outstanding, reports no sales in the past three months, and identifies Wells Fargo Clearing Services as the broker.